Modulation of antigen-specific T-cells as immune therapy for chronic infectious diseases and cancer

8Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

T-cell responses are induced by antigen presenting cells (APC) and signals from the microenvironment. Antigen persistence and inflammatory microenvironments in chronic infections and cancer can induce a tolerant state in T-cells resulting in hyporesponsiveness, loss of effector function, and weak biochemical signaling patterns in response to antigen stimulation. Although the mechanisms of T-cell tolerance induced in chronic infection and cancer may differ from those involved in tolerance to self-antigen, the impaired proliferation and production of IL-2 in response to antigen stimulation are hallmarks of all tolerant T cells. In this review, we will summarize the evidence that the immune responses change from non-self to "self"-like in chronic infection and cancer, and will provide an overview of strategies for re-balancing the immune response of antigen-specific T cells in chronic infection and cancer without affecting the homeostasis of the immune system. © 2014 Li, Symonds, Miao, Sanderson and Wang.

Cite

CITATION STYLE

APA

Li, S., Symonds, A. L. J., Miao, T., Sanderson, I., & Wang, P. (2014). Modulation of antigen-specific T-cells as immune therapy for chronic infectious diseases and cancer. Frontiers in Immunology. Frontiers Research Foundation. https://doi.org/10.3389/fimmu.2014.00293

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free